POC Molecular Diagnostics - Worldwide Market Analysis & Forecast Through 2019-2023 with Abbott, bioMerieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, and Qiagen Leading the Competition - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 7, 2019--The “Global POC Molecular Diagnostics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The POC molecular diagnostics market will register a CAGR of almost 14% by 2023.
Growing focus on technological advances to drive growth in the market
The increasing focus on the development of technologically advanced POC molecular diagnostic products will result in the augmented adoption of these products. These advanced devices decrease the workload of end-users and offer results within limited time. Therefore, to increase the efficiency and effectiveness of the results, the companies are developing advanced products.
Growing number of M&A and collaborations
Large companies are increasingly acquiring and collaborating with specialized POC molecular diagnostic companies to expand their product portfolio. Collaboration would result in the development of additional POC tests which can be offered across the globe, thereby expanding the company’s reach.
End-users rely on companies that provide high-quality products. When products lead to patient injury or fatalities, manufacturers wither voluntarily recall them from the market. This affects the market growth and brand image.
Key PlayersAbbott bioMerieux Bio-Rad Laboratories Danaher F. Hoffmann-La Roche QIAGEN
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY APPLICATIONMarket segmentation by application Comparison by application Infectious diseases - Market size and forecast 2018-2023 Oncology - Market size and forecast 2018-2023 Hematology and endocrinology - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY TECHNOLOGYMarket segmentation by technology Comparison by technology PCR (gene sequencing) - Market size and forecast 2018-2023 Microarray and hybridization - Market size and forecast 2018-2023 Market opportunity by technology
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDSGrowing focus on technological advances Liquid biopsy as an emerging trend Presence of government funding
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors Abbott bioMerieux Bio-Rad Laboratories Danaher F. Hoffmann-La Roche QIAGEN
For more information about this report visit https://www.researchandmarkets.com/research/bmb5mw/poc_molecular?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190107005635/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Point-of-Care Diagnostics,Molecular Diagnostics
KEYWORD: ASIA PACIFIC NORTH AMERICA
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/07/2019 08:56 AM/DISC: 01/07/2019 08:56 AM